InsidersTradesSigma
Browse the full management transaction log of Marinomed Biotech AG, a listed issuer based in Austria. Shares are listed on AT AT, under the supervision of FMA (OeKB OAM). Operating in the Healthcare & Pharma sector, Marinomed Biotech AG has published 23 public disclosures. Market capitalisation: €26.7m. The latest transaction was disclosed on 15 April 2026 — Purchase. Among the most active insiders: Unknown. All data is openly available.
FY ended December 2024 · cache
0 of 0 declarations